(NASDAQ:ORIC), SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced a poster presentation highlighting data from a Phase 1b trial of enozertinib (ORIC-114) at the ESMO Asia Congress 2025 […]

(NASDAQ:FUSE),(NASDAQ:FUSEW), NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Fusemachines Inc. (“Fusemachines”) (NASDAQ: FUSE), a leading provider of enterprise AI technologies, and RentRedi, the fastest-growing rental management software built for smart independent landlords and their tenants, are embarking on a joint endeavor to offer more AI-powered solutions through an integration with AI Studio for Real

(NYSE:FCX), LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Freeport-McMoRan Inc. (“Freeport” or “the Company”) (NYSE: FCX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders

(CNSX:SHRC.CN),(OTC US:INTWF),(Other OTC:INTWF),(Frankfurt:IWIA),(CNSX:SHRC), VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC Energy” or the “Company”) is pleased to announce it has filed financial results for the three and nine months ended September 30, 2025. All figures are in Canadian Dollars and in accordance

(NYSE MKT: VTAK), Fort Mill, SC, Dec. 01, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced the successful launch of its LockeT suture retention device in Switzerland. The first clinical cases were performed at

(NasdaqGM:STRO), SOUTH SAN FRANCISCO, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that its Board of Directors (Board) has approved a reverse stock split of the Company's outstanding shares of common stock

(NASDAQ:DARE), SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — DareÌ Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that all rights to Ovaprene(R), the company's first-in-category, investigational, hormone-free monthly intravaginal contraceptive, will be returned to Dare by

Copenhagen, Denmark, Dec. 01, 2025 (GLOBE NEWSWIRE) — O2matic ApS, a digital health company pioneering autonomous oxygen therapy and monitoring technologies, announced today that its proprietary oxygen titration system will be evaluated in a new U.S.-based research initiative led by the University of Colorado (CU) Anschutz School of Medicine. Funded by the U.S. Department of

WAYNE, N.J. and CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Zwanger-Pesiri Radiology, one of the most respected and technologically advanced outpatient radiology practices in the Northeast, has implemented Bone Suppression Imaging (BSI) technology from Konica Minolta Healthcare Americas, Inc., to support more precise visualization of pulmonary abnormalities on chest X-rays. Konica Minolta's BSI suppresses the

(NASDAQ:INMB), Boca Raton, FL, Dec. 01, 2025 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing inflammation and immunology therapies targeting innate immune dysfunction, announces new neuroimaging data from its Phase 2 MINDFuL trial of XPro1595 in patients with early Alzheimer's disease (AD) and elevated neuroinflammation. The results will be presented